Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography

Abstract Background To determine the effect of various factors to the preservation rate of the conjunctival layer borderlines of glaucomatous eyes treated with anti-glaucoma eye drops. Methods Anterior segment optical coherence tomography (AS-OCT) images of the bulbar conjunctiva of 328 eyes were an...

Full description

Bibliographic Details
Main Authors: Makoto Gozawa, Yoshihiro Takamura, Kentaro Iwasaki, Shogo Arimura, Masaru Inatani
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Ophthalmology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12886-020-01518-6
_version_ 1819205970916540416
author Makoto Gozawa
Yoshihiro Takamura
Kentaro Iwasaki
Shogo Arimura
Masaru Inatani
author_facet Makoto Gozawa
Yoshihiro Takamura
Kentaro Iwasaki
Shogo Arimura
Masaru Inatani
author_sort Makoto Gozawa
collection DOAJ
description Abstract Background To determine the effect of various factors to the preservation rate of the conjunctival layer borderlines of glaucomatous eyes treated with anti-glaucoma eye drops. Methods Anterior segment optical coherence tomography (AS-OCT) images of the bulbar conjunctiva of 328 eyes were analyzed with and without anti-glaucoma eye drops to quantify the preservation rates of the conjunctival layer borderlines. Results More anti-glaucoma eye drops and a longer duration of administration were associated with lower preservation rates of the borderlines between both the conjunctival stroma/Tenon’s capsule (P < 0.001 and P < 0.001, respectively) and Tenon’s capsule/sclera (P < 0.001 and P < 0.001, respectively). Prostaglandin analogs and fixed combinations of β-blockers/prostaglandin analogs were prognostic factors for lower preservation rates of the borderlines between both the conjunctival stroma/Tenon’s capsule (P < 0.001 and P = 0.009, respectively) and Tenon’s capsule/sclera (P < 0.001 and P = 0.008, respectively). Conclusions Numerous anti-glaucoma eye drops and their long-term administration are associated with the disruption of the bulbar conjunctival borderlines detected by AS-OCT.
first_indexed 2024-12-23T05:00:10Z
format Article
id doaj.art-6856880c905a4fdd9ab5f69eaaa8a8ff
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-12-23T05:00:10Z
publishDate 2020-06-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-6856880c905a4fdd9ab5f69eaaa8a8ff2022-12-21T17:59:15ZengBMCBMC Ophthalmology1471-24152020-06-012011710.1186/s12886-020-01518-6Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomographyMakoto Gozawa0Yoshihiro Takamura1Kentaro Iwasaki2Shogo Arimura3Masaru Inatani4Department of Ophthalmology, Faculty of Medical Sciences, University of FukuiDepartment of Ophthalmology, Faculty of Medical Sciences, University of FukuiDepartment of Ophthalmology, Faculty of Medical Sciences, University of FukuiDepartment of Ophthalmology, Faculty of Medical Sciences, University of FukuiDepartment of Ophthalmology, Faculty of Medical Sciences, University of FukuiAbstract Background To determine the effect of various factors to the preservation rate of the conjunctival layer borderlines of glaucomatous eyes treated with anti-glaucoma eye drops. Methods Anterior segment optical coherence tomography (AS-OCT) images of the bulbar conjunctiva of 328 eyes were analyzed with and without anti-glaucoma eye drops to quantify the preservation rates of the conjunctival layer borderlines. Results More anti-glaucoma eye drops and a longer duration of administration were associated with lower preservation rates of the borderlines between both the conjunctival stroma/Tenon’s capsule (P < 0.001 and P < 0.001, respectively) and Tenon’s capsule/sclera (P < 0.001 and P < 0.001, respectively). Prostaglandin analogs and fixed combinations of β-blockers/prostaglandin analogs were prognostic factors for lower preservation rates of the borderlines between both the conjunctival stroma/Tenon’s capsule (P < 0.001 and P = 0.009, respectively) and Tenon’s capsule/sclera (P < 0.001 and P = 0.008, respectively). Conclusions Numerous anti-glaucoma eye drops and their long-term administration are associated with the disruption of the bulbar conjunctival borderlines detected by AS-OCT.http://link.springer.com/article/10.1186/s12886-020-01518-6GlaucomaConjunctivaAnterior segment optical coherence tomographyAnti-glaucoma eye drops
spellingShingle Makoto Gozawa
Yoshihiro Takamura
Kentaro Iwasaki
Shogo Arimura
Masaru Inatani
Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
BMC Ophthalmology
Glaucoma
Conjunctiva
Anterior segment optical coherence tomography
Anti-glaucoma eye drops
title Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
title_full Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
title_fullStr Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
title_full_unstemmed Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
title_short Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
title_sort conjunctival structure of glaucomatous eyes treated with anti glaucoma eye drops a cross sectional study using anterior segment optical coherence tomography
topic Glaucoma
Conjunctiva
Anterior segment optical coherence tomography
Anti-glaucoma eye drops
url http://link.springer.com/article/10.1186/s12886-020-01518-6
work_keys_str_mv AT makotogozawa conjunctivalstructureofglaucomatouseyestreatedwithantiglaucomaeyedropsacrosssectionalstudyusinganteriorsegmentopticalcoherencetomography
AT yoshihirotakamura conjunctivalstructureofglaucomatouseyestreatedwithantiglaucomaeyedropsacrosssectionalstudyusinganteriorsegmentopticalcoherencetomography
AT kentaroiwasaki conjunctivalstructureofglaucomatouseyestreatedwithantiglaucomaeyedropsacrosssectionalstudyusinganteriorsegmentopticalcoherencetomography
AT shogoarimura conjunctivalstructureofglaucomatouseyestreatedwithantiglaucomaeyedropsacrosssectionalstudyusinganteriorsegmentopticalcoherencetomography
AT masaruinatani conjunctivalstructureofglaucomatouseyestreatedwithantiglaucomaeyedropsacrosssectionalstudyusinganteriorsegmentopticalcoherencetomography